BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37479586)

  • 21. Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer With Occult Lymph Node Disease.
    Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
    Ann Thorac Surg; 2023 Jun; 115(6):1344-1351. PubMed ID: 36126718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    Osarogiagbon RU; Lee YS; Faris NR; Ray MA; Ojeabulu PO; Smeltzer MP
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1220-1229.e2. PubMed ID: 31147169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to Survival.
    Edwards T; Balata H; Elshafi M; Foden P; Bishop P; Fontaine E; Jones M; Krysiak P; Rammohan K; Shah R; Crosbie P; Booton R; Evison M
    J Thorac Oncol; 2017 Dec; 12(12):1845-1850. PubMed ID: 28782727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
    Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
    JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
    Moon Y; Choi SY; Park JK; Lee KY
    World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    Kneuertz PJ; Cheufou DH; D'Souza DM; Mardanzai K; Abdel-Rasoul M; Theegarten D; Moffatt-Bruce SD; Aigner C; Merritt RE
    J Thorac Cardiovasc Surg; 2019 Nov; 158(5):1457-1466.e2. PubMed ID: 31623811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Lung Cancer Surgical Technique on Lymph Node Sampling and Pathologic Nodal Upstaging.
    Kalata S; Mollberg NM; He C; Clark M; Theurer P; Chang AC; Welsh RJ; Lagisetty KH
    Ann Thorac Surg; 2023 May; 115(5):1238-1245. PubMed ID: 36240869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consolidation/Tumor Ratio on Chest Computed Tomography as Predictor of Postoperative Nodal Upstaging in Clinical T1N0 Lung Cancer.
    Moon Y; Park JK; Lee KY; Namkoong M; Ahn S
    World J Surg; 2018 Sep; 42(9):2872-2878. PubMed ID: 29450699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?
    David EA; Cooke DT; Chen Y; Nijar K; Canter RJ; Cress RD
    Ann Thorac Surg; 2017 Jan; 103(1):226-235. PubMed ID: 27469339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    Turna A; Melek H; Kara HV; Kılıç B; Erşen E; Kaynak K
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):789-795. PubMed ID: 29110950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
    Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robotic resection of Stage III lung cancer: an international retrospective study.
    Veronesi G; Park B; Cerfolio R; Dylewski M; Toker A; Fontaine JP; Hanna WC; Morenghi E; Novellis P; Velez-Cubian FO; Amaral MH; Dieci E; Alloisio M; Toloza EM
    Eur J Cardiothorac Surg; 2018 Nov; 54(5):912-919. PubMed ID: 29718155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of nodal upstaging in patients with cT1-3N0 non-small cell lung cancer (NSCLC): results from the Italian VATS Group Registry.
    Marulli G; Faccioli E; Mammana M; Nicotra S; Comacchio G; Verderi E; De Palma A; Rea F;
    Surg Today; 2020 Jul; 50(7):711-718. PubMed ID: 31873770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.
    Hoang JK; Patz E; Giroux D; Goldstraw P
    J Thorac Oncol; 2007 Dec; 2(12):1103-6. PubMed ID: 18090582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wedge resection of the bronchus: an alternative bronchoplastic technique for preservation of lung tissue.
    Kotoulas C; Lazopoulos G; Foroulis C; Konstantinou M; Tomos P; Lioulias A
    Eur J Cardiothorac Surg; 2001 Oct; 20(4):679-83. PubMed ID: 11574207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.